Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history

JAMA

Volumn 292, Issue 12, 2004, Pages 1480-1489

  Murff, Harvey J ^a   Spigel, David R ^b   Syngal, Sapna ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SARAH CANNON RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COLON CANCER; DATA ANALYSIS; DATA BASE; DEATH CERTIFICATE; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FAMILY HISTORY; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; INFORMATION RETRIEVAL; MEDICAL RECORD; OVARY CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCIBILITY; REVIEW; SELF REPORT; ANAMNESIS; FAMILY; GENETICS; NEOPLASM; PEDIGREE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MEDICAL HISTORY TAKING; NEOPLASMS; PEDIGREE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 4544308586     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.12.1480     Document Type: Review

References (106)

1. Lynch HT, Brodkey FD, Lynch P, et al. Familial risk and cancer control. JAMA. 1976;236:582-584.
2. Weber W, Gencik A, Muller H. Familial cancer: consequences for the oncological practice. Cancer Detect Prev. 1986;9:455-458.
3. Pharoah PD, Day NE, Duffy S, et al. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997;71:800-809.
4. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493-499.
5. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol. 2000;182:23-29.
6. Gruber SB, Thompson WD; Cancer and Steroid Hormone Study Group. A population-based study of endometrial cancer and familial risk in younger women. Cancer Epidemiol Biomarkers Prev. 1996;5:411-417.
7. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol. 1993;10:235-244.
8. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669-1674.
9. St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993;118:785-790.
10. Weber W. Cancer control by family history. Anticancer Res. 1993;13:1197-1201.
11. Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology. 2000;56:803-806.
12. Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol. 1996;144:1041-1047.
13. Cerhan JR, Parker AS, Putnam SD, et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev. 1999;8:53-60.
14. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-1456.
15. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-932.
16. Shattuck-Eldens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA. 1997;278:1242-1250.
17. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397-2406.
18. US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137:344-346.
19. US Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137:915-916.
20. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129-131.
21. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2001;51:38-75.
22. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst. 1997;89:1015-1026.
23. Ferrini R, Mannino E, Ramsdell E, Hill L. Screening mammography for breast cancer: American College of Preventive Medicine practice policy statement. Am J Prev Med. 1996;12:340-341.
24. American Academy of Family Physicians. Periodic health examinations: summary of policy recommendations for periodic health examinations. Available at: http://www.aafp.org/PreBuilt/PHErev54.pdf. Accessed August 26, 2004.
25. Burt RW, Bishop DT, Lynch HT, Rozen P, Winawer SJ. Risk and surveillance of individuals with heritable factors for colorectal cancer: WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68:655-665.
26. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-560.
27. Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992;42:296-299.
28. Burke W, Daly M, Garber J, et al; Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, II: BRCA1 and BRCA2. JAMA. 1997;277:997-1003.
29. Burke W, Petersen G, Lynch P, et al; Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, I: hereditary nonpolyposis colon cancer. JAMA. 1997;277:915-919.
30. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994;55:S4-S14.
31. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
32. Cauley JA, Norton L, Lippman ME, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Breast Cancer Res Treat. 2001;65:125-134.
33. Hartmann LC, Schald DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med: 1999;340:77-84.
34. Severin MJ. Hereditary cancer litigation: a status report. Oncology (Huntingt). 1996;10:211-214, 217.
35. Douglas FS, O'Dair LC, Robinson M, Evans DG, Lynch SA. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet. 1999;36:309-312.
36. Kerr B, Foulkes WD, Cade D, et al. False family history of breast cancer in the family cancer clinic. Eur J Surg Oncol. 1998;24:275-279.
37. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002;20:528-537.
38. Fry A, Campbell H, Gudmunsdottir H, et al. GPs' views on their role in cancer genetics services and current practice. Fam Pract. 1999;16:468-474.
39. Emery J, Rose P. Expanding the role of the family history in primary care [editorial]. Br J Gen Pract. 1999;49:260-261.
40. Harris R, Harris H. Genetics in primary care: report on workshop of EC Concerted Action on Genetics Services in Europe (CAGSE) in association with the Royal College of GP Spring Meeting, Blackpool, UK, 28 April 1995. J Med Genet. 1996;33:346-348.
41. Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract. 1999;16:426-445.
42. Hunter A, Wright P, Cappelli M, Kasaboski A, Surh L. Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet. 1998;53:447-455.
43. Gollust SE, Hull SC, Wilfond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA. 2002;288:1762-1767.
44. Sijmons RH, Boonstra AE, Reefhuis J, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet. 2000;8:181-186.
45. Johnson N, Lancaster T, Fuller A, Hodgson SV. The prevalence of a family history of cancer in general practice. Fam Pract. 1995;12:287-289.
46. Scheuner MT, Wang SJ, Raffel U, Larabell SK, Rotter JI. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet. 1997;71:315-324.
47. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk: the Utah Population Database. JAMA. 1993;270:1563-1568.
48. Hughes KS, Roche C, Campbell CT, et al. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J. 2003;9:19-25.
49. Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol. 2002;20:2658-2663.
50. Lynch HT, Kimberling W, Albano WA, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II), I: clinical description of resource. Cancer. 1985;56:934-938.
51. Thompson WD, Schildkraut JM. Family history of gynaecological cancers: relationships to the incidence of breast cancer prior to age 55. Int J Epidemiol. 1991;20:595-602.
52. Parazzini F, La Vecchia C, Negri E, Franceschi S, Tozzi L. Family history of breast, ovarian and endometrial cancer and risk of breast cancer. Int J Epidemiol. 1993;22:614-618.
53. Schmidt S, Becher H, Chang-Claude J. Breast cancer risk assessment: use of complete pedigree information and the effect of misspecified ages at diagnosis of affected relatives. Hum Genet. 1998;102:348-356.
54. Bennett RL, Steinhaus KA, Uhrich SB, et al. Reccommendations for standardized human pedigree nomenclature. Am J Hum Genet. 1995;56:745-752.
55. Bennett RL. The Practical Guide to the Genetic Family History. New York, NY: Wiley-Liss; 1999.
56. Mussio P, Weber W, Brunetti D, Stemmermann GN, Torhorst J. Taking a family history in cancer patients with a simple questionnaire. Anticancer Res. 1998;18:2811-2814.
57. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 1995;76:2343-2350.
58. Hawkins MM, Swerdlow AJ. Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. Br J Cancer. 1992;66:408-413.
59. Penberthy L, McClish D, Pugh A, et al. Using hospital discharge files to enhance cancer surveillance. Am J Epidemiol. 2003;158:27-34.
60. Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort: accuracy and delay. Acta Oncol. 2002;41:381-388.
61. Dickinson NO, Salotti JA, Birch PJ, et al. How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales? J Epidemiol Community Health. 2001;55:414-422.
62. Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med. 2000;132:705-710.
63. Bergmann MM, Calle EE, Mervis CA, et al. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol. 1998;147:556-562.
64. Mukherjee AK, Leck I, Langley FA, Ashcroft C. The completeness and accuracy of health authority and cancer registry records according to a study of ovarian neoplasms. Public Health. 1991;105:69-78.
65. Izquierdo JN, Schoenbach VJ. The potential and limitations of data from population-based state cancer registries. Am J Public Health. 2000;90:695-698.
66. James DS, Bull AD. Information on death certificates: cause for concern? J Clin Pathol. 1996;49:213-216.
67. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985;313:1263-1269.
68. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis. 1985;38:289-293.
69. Breuer B, Kash KM, Rosenthal G, Diemer K, Osborne MP, Miller DG. Reporting bilaterality status in first-degree relatives with breast cancer: a validity study. Genet Epidemiol. 1993;10:245-256.
70. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev. 1994;3:321-327.
71. Aitken J, Bain C, Ward M, Siskind V, MacLennan R. How accurate is self-reported family history of colorectal cancer? Am J Epidemiol. 1995;141:863-871.
72. Parent ME, Ghadirian P, Lacroix A, Perret C. Accuracy of reports of familial breast cancer in a case-control series. Epidemiology. 1995;6:184-186.
73. Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. Genet Epidemiol. 1996;13:193-205.
74. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol. 1997;146:244-248.
75. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer. 2000;36:1143-1148.
76. Katballe N, Juul S, Christensen M, Orntoft TF, Wikman FP, Laurberg S. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg. 2001;88:1228-1233.
77. King TM, Tong L, Pack RJ, Spencer C, Amos CI. Accuracy of family history of cancer as reported by men with prostate cancer. Urology. 2002;59:546-550.
78. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 2003;24:190-198.
79. Mitchell RJ, Brewster D, Campbell H, et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53:291-295.
80. Verkooijen HM, Fioretta G, Chappuis PO, et al. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol. 2004;15:350-353.
81. Ivanovich J, Babb S, Goodfellow P, et al. Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. Clin Cancer Res. 2002;8:1849-1856.
82. Koch M, Hill GB. Problems in establishing accurate family history in patients with ovarian cancer of epithelial origin. Cancer Detect Prev. 1987;10:279-283.
83. Douglas FS, O'Dair LC, Robinson M, et al. The accuracy of diagnosis as reported in families with cancer: a retrospective study. J Med Genet. 1999;36:309-312.
84. Gierlowski TC, Ron E, Schneider AB. The accuracy of siblings' family history reports of thyroid and other cancers. Am J Public Health. 1995;85:408-409.
85. Novakovic B, Goldstein AM, Tucker MA. Validation of family history of cancer in deceased members. J Natl Cancer Inst. 1996;88:1492-1943.
86. Kuijten RR, et al. Validation and accuracy of cancer reporting in first-degree relatives [abstract]. Am J Epidemiol. 1992;12:1019.
87. Airewele G, Adatto P, Cunningham J, et al. Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst. 1998;90:543-544.
88. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol. 1994;47:89-96.
89. Salkind AR, Cuddy PG, Foxworth JW. Is this patient allergic to penicillin? an evidence-based analysis of the likelihood of penicillin allergy. JAMA. 2001;285:2498-2505.
90. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763-770.
91. Garbers V, Toniolo PG, Taioli E. Changes in self-reported family history of breast cancer with change in case-control status. Eur J Epidemiol. 2001;17:517-520.
92. Novakovic B, Goldstein AM, Tucker MA. Validation of family history of cancer in deceased family members. J Natl Cancer Inst. 1996;88:1492-1493.
93. Weinstock MA, Brodsky GL. Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol. 1998;51:1299-1303.
94. Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153:299-306.
95. Loescher U. The family history component of cancer genetic risk counseling. Cancer Nurs. 1999;22:96-102.
96. Blumenthal D, Causino N, Chang YC, et al. The duration of ambulatory visits to physicians. J Fam Pract 1999;48:264-271.
97. Cole J, Conneally PM, Hodes ME, Merritt AD. Genetic family history questionnaire. J Med Genet. 1978;15:10-18.
98. Gilpin CA, Carson N, Hunter AG. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet. 2000;58:299-308.
99. Gerson R, McGoldrick M. The computerized genogram. Prim Care. 1985;12:535-545.
100. Ebell MH, Heaton CJ. Development and evaluation of a computer genogram. J Fam Pract. 1988;27:536-538.
101. Westman J, Hampel H, Bradley T. Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000;37:354-360.
102. Emery J. Computer support for genetic advice in primary care. Br J Gen Pract. 1999;49:572-575.
103. Green MJ, Fost N. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. J Cancer Educ. 1997;12:204-208.
104. Green MJ, Fost N. Who should provide genetic education prior to gene testing? computers and other methods for improving patient understanding. Genet Test. 1997;1:131-136.
105. Rose P, Humm E, Hey K, Jones L, Huson SM. Family history taking and genetic counselling in primary care. Fam Pract. 1999;16:78-83.
106. Fletcher SW, Elmore JG. Clinical practice: mammographic screening for breast cancer. N Engl J Med. 2003;348:1672-1680.